FDA Inspection 752499 — Arizona Center for Reproductive Endocrinology & Infertility

Arizona Center for Reproductive Endocrinology & Infertility — FEI 3005391124

The FDA completed an inspection of Arizona Center for Reproductive Endocrinology & Infertility on November 3, 2011 in Tucson, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 3, 2011
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tucson, AZ (United States)